AHA Coding Clinic® for HCPCS - 2004 Issue 2; FOR your INFORMATION

Pass-through payment for newly approved drugs and biologicals

The following drugs were designated eligible for pass-through payment under the OPPS by CMS, effective April 1, 2004. HCPCSEffective date for pass-through statusSIAPCShort descriptorLong descriptorPayment rateMinimum unadjusted copaymentEffective date for payment rateC9124 4/1/2004 G 9124 Injection, daptomycin Injection, daptomycin, per 1 mg $0.31 $0.05 1/1/2004 C9125 4/1/2004 G 9125 Injection, risperidone Injection, risperidone, per 12.5 mg $131.86 $19.71 1/1/2004 J2783 4/1/2004 G 0738 Rasburicase Injection, rasburicase, 0.5 mg $105.54 $17.63 4/1/2004 These payments will be temporary until there is sufficient cost data from outpatient services to develop an appropriate price within...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.

Thank you for choosing Find-A-Code, please Sign In to remove ads.